Cannabis and the UK investor – two years on

A version of this blog has been posted by Law360 on 26 October 2020

30 October 2020

Headlines such as “Spain becomes cannabis hub as criminals fill tourism void” (The Guardian 9 October 2020) serve to remind us of the endemic demand for marijuana, the resultant profits to be made and enforcement agencies’ inability to control Europe’s illegal trade run by drug mafias. By contrast, Canada, on 17 October 2018 and following the example of Uruguay, elected to legalise adult personal possession, sharing and cultivation of recreational cannabis.

As foreseen by many investors, the Canadian cannabis industry has thrived in the last two years, with various market forecasts indicating that it could be worth between C$4.9bn and C$8.7bn (approx. £2.8 to £5bn) annually from 2021, with some predicting the market size will be worth C$97.35bn (approx. £56bn) by 2026. In the US there is said to have been a meteoric rise in Cannabis SPAC (Special Purpose Acquisition Companies) IPO’s providing private marijuana and hemp companies an unprecedented opportunity to raise money and go public (e.g. in 2019 $2.6 billion; $700 million in the first half of 2020).

Where does this leave a UK investor, anxious to reap such rewards by cannabis investment in a former crown colony?

To recap

At the time of the Canadian legislation, we wrote about the problems for UK investors (individuals and corporates) potentially falling foul of the Proceeds of Crime Act 2002 (POCA) by committing money laundering offences if they invested in the Canadian cannabis industry. Cannabis is a Class B drug and cultivation, possession or supply is illegal here in the UK (there are a few exceptions in respect of medicinal cannabis which we deal with below). Under POCA, ‘criminal property’ is given a wide definition as property which represents a person’s benefit from any conduct which would amount to a criminal offence in the UK if it were to occur here. As such, under the strict letter of the law, proceeds made legitimately in the cannabis industry in Canada (or elsewhere) will be ‘criminal property’ in the UK. The possessor of such property would commit a money-laundering offence in the UK, making them potentially liable for prosecution and confiscation of that property. The exceptions introduced under the Serious Organised Crime and Police Act 2005 (SOCPA) – colloquially known as the ‘Spanish Bullfighter Exception’ – do not assist UK investors here, as all offences related to cannabis are punishable by a term of imprisonment greater than 12 months.

As we wrote, the only way to avoid committing a money laundering offence would be to seek a Defence Against Money Laundering (DAML) from the NCA which involves seeking their consent before dealing with criminal property; in which case no offence is committed under POCA.

Developments in the UK in the last two years

So what developments have there been since?

(1)November 2018 – partial legalisation of medicinal cannabis

In November 2018 the supply of cannabis-based products for certain medical conditions was made lawful in the UK. Nevertheless, it is tightly regulated and a licence is required. This may assist an investor who invests in a Canadian cannabis company which produces medicinal cannabis only on the same basis as those licensed in the UK. However, this is untested and in reality it is doubtful that such a company would exist in Canada (see below FCA guidance for listing of cannabis related businesses).

Moreover, there is currently no government policy pertaining to the conditions that these products can be prescribed for. For example, the laws governing CBD products are somewhat vague creating a large amount of confusion over the allowable THC limits in hemp-derived CBD products. Some of these regulations are EU driven and it remains uncertain what will happen as the UK exits the European Union.

(2)December 2018 – Lloyds of London circular re the insurance industry

The following month, Lloyds of London published a circular that suggested adopting a purposive interpretation of POCA, providing that insurance in respect of Canadian cannabis risks would not meet the dual criminality test. This was on the basis that POCA was not designed to preclude “wholly lawful conduct such as the provision of insurance of business activity carefully legalised in another country”. Again this interpretation is untested (and some commentators question its accuracy) so cannot be relied on by an investor.

(3)June 2019 – the Law Commission calls for guidance in relation to transactions involving the legal cannabis industry

This featured in the Law Commission’s report on the suspicious activity report (SAR) regime because of the huge increase in DAML applications in respect of the legal cannabis industry (as referred to above).

UK Finance, a trade association for the UK banking and financial services sector, was consulted by the Law Commission on the SAR regime and its applicability to cannabis investors. It is quoted as saying that "common sense would suggest that reports about dealings with the proceeds of such lawful businesses would be of no actionable or intelligence value to law enforcement, but the legal position is less clear".

No such guidance has been provided and as such DAMLs have to be made for each and every transaction. Commentators have opined that they expect a further increase in the number of SARs being filed about lawful cannabis production overseas.

(4)September 2020 – FCA guidance for listing of cannabis related businesses

On 18 September 2020, the Financial Conduct Authority (FCA) published a statement regarding listing of cannabis-related businesses due to the dearth of guidance in any form. Whilst an FCA guidance consultation is pending and will follow in due course, the FCA’s view is that “there remains a risk that the proceeds from overseas medicinal cannabis business may constitute ‘criminal property’ for the purpose of POCA. This includes where the company possesses a licence issued by an overseas medicines or pharmaceuticals licensing authority.” The FCA is clear that “proceeds from recreational cannabis companies, even when they are located in those jurisdictions that have legalised it, are the proceeds of crime under POCA.

Regarding recreational cannabis companies, the FCA had made plain that the securities of those companies, even those in jurisdictions where it is entirely legal, will not be admitted to the Official List. UK-based medical cannabis companies can be admitted to the Main Market as long as they have the appropriate UK Home Office licences in place. Overseas-licensed medical cannabis companies will be assessed on a case-by-case basis. In order to be admitted to the Main Market, the FCA must be satisfied that POCA does not apply and the usual criteria for listing are met.

The FCA guidance provides clarity for foreign cannabis companies dealing exclusively in medicinal cannabis (despite the significant due diligence required by the FCA to prove that the company does not contravene POCA) and for companies that are fully licensed for all their activities in the UK. Hence for those who invest in such companies admitted to the Main Market; POCA poses no threat to the investor. However, it is restricted to these cases.

So what does the future hold for cannabis UK investors?

It follows from the above that since October 2018 very little progress has been made towards changing the legal position for UK investors. Conversely, there is little appetite by the UK enforcement agencies to prosecute these offences; not one prosecution has yet been brought. On one view this might be encouraging for the UK investor. Equally, it means that there has been no test case to provide any guidance. So, until there is such guidance or a change in the law, the only comfort for an investor is to seek a DAML.

Meanwhile, a report in December 2019 from Prohibition Partners forecasts the UK legal cannabis market to reach £2.31bn by 2024. The cannabis investment sector that is gaining traction in Europe is also turning its attention towards the UK market, the report notes. Numerous consultancies, market research and cannabis-focused finance groups have opened up in London – the city also playing host to the annual Cannabis Europa Conference. It adds that “Major cannabis companies are also having success in the UK. GW Pharmaceuticals, the largest exporter of legal medical cannabis in the world, is headquartered in England, and operates numerous sites across the south of the country. Joining them are numerous foreign cannabis industry giants… which have recently put down roots in the UK through the establishment of subsidiaries in order to secure competitive footholds in a UK market that is primed for expansion”.

In addition, there have been many calls for reform. In April 2019, Arfon Jones, Police and Crime Commissioner for North Wales, has called for the British Government to regulate cannabis to help prevent the rise in criminal gangs. In July 2019, a cross-party group of MPs went on a fact-finding trip to Canada to learn about the country’s approach to cannabis. They predicted that recreational cannabis will be fully legalised in the UK in five to ten years. A poll taken in December 2019 revealed that 53% of UK adults would support legalisation in some form. However, there is no indication that this will happen any time soon or indeed if at all.

A version of this blog was published by Law360 on 26 October 2020. You can read this article by clicking here.

Further information

For further information on issues raised within this news piece, please contact a member of our team.


About the authors

Nicola Finnerty is a partner in the criminal litigation team. She has experience of fraud, corruption  (including the Bribery Act) and cartel matters, financial compliance, money laundering, asset seizure and confiscation cases, through to sexual offence casesdrugsmurder and offensive weapon crimes.

Tom Surr is the Head Paralegal in the Criminal Litigation Department of Kingsley Napley. He is a former police officer, having served in the Met Police for just over two years as the Dedicated Ward Officer for the ward of Kilburn in North-West London. He left the police to pursue a career in law, working briefly in the Crown Prosecution Service’s Extradition Unit as a paralegal before joining Kingsley Napley.


This blog has been co-authored by Tom Surr, Head Paralegal in our Criminal Litigation Department.

Latest blogs & news

The emergence of the private medical cannabis market and the risks of private prescriptions

In September 2020, the first NHS prescription for cannabis medicine was issued to Billy Caldwell. This brought hope to him, his family and so many others that this medicine would become readily available to those patients who so desperately need it.

Medicinal Cannabis – Where Are We Now?

Guest author Edward Henry QC, of Mountford Chambers, considers the ongoing issues regarding access to medicinal cannabis, specifically relating to the treatment of children, in the United Kingdom (UK).

Exploring cannabis regulations and investment in the UK

As the regulatory landscape around cannabis in the UK evolves, investors are looking toward cannabis companies as a socially conscious investment, but in the UK, the drug is a controlled substance, as such, careful considerations need to be borne in mind. Here, Shannett Thompson explains the legal landscape around cannabis and its implications for investing in cannabis as a UK national.

Met Police appetite for Account Freezing Orders undimmed by pandemic

Account Freezing Orders (AFrOs) are a measure introduced by the Criminal Finances Act 2017 and have been available to a wide range of law enforcement agencies since February 2018.

The FCA proposes new listing guidance for cannabis-related businesses – a positive step for investors concerned about the Proceeds of Crime Act

In September 2020 the FCA published a statement regarding the listing of cannabis-related businesses (CRBs) in the UK. Since then several CRBs have been admitted to the London Stock Exchange (LSE) and appetite for investments in the medicinal cannabis industry continues to grow.

Will the CPS’ decision to update its guidance mean an increase in prosecutions for failure to disclose under section 330 of POCA 2002?

Recent guidance issued by the CPS on the offence of ‘failure to disclose’ under section 330 of the Proceeds of Crime Act 2002 (‘POCA 2002’) states that it is now “possible to charge an individual under section 330 even though there is insufficient evidence to establish that money laundering was planned or has taken place.”

To date, there have seldom been prosecutions for this offence but this guidance – effectively removing a significant element of the offence - suggests that the CPS may be looking to bring more charges in the future.

The risks and penalties of money laundering for charities and how to guard against it

Money launderers will look for any opportunity to take advantage of organisations with weak financial controls in order to launder their ill-gotten gains. Charities, trustees, employees and volunteers who knowingly or unwittingly assist money launderers, or who fail to report suspicions, may commit a criminal offence and find themselves liable to prosecution. 

HMRC’s record fine for money laundering breaches

HMRC monitors over 30,000 businesses to ensure their compliance with the Money Laundering, Terrorist Financing and Transfer of Funds (Information on the Payer) Regulations 2017 (the regulations). Businesses which are found to have breached their regulatory obligations are at risk of civil and even criminal penalties.

Another Civil Recovery Settlement: SFO v Julio Faerman

On 12 November the SFO announced that it had secured an agreement from Julio Faerman to pay a total of £1,198,424.78, following a civil recovery investigation into his UK assets. These assets included a £4.25m luxury apartment in West London which the SFO suspected to have been partly purchased with funds derived from its owner’s corruption.

A consistent approach to extensions of moratorium periods for Suspicious Activity Reports

The Government has published a circular on extensions to the moratorium period for Suspicious Activity Reports (SARs), which acts as a restatement of the law and aims to ensure consistency in practice by law enforcement agencies in relation to the Defence Against Money Laundering (DAML) regime under section 335 of the Proceeds of Crime Act 2002 (POCA). The circular, published September 2020, sets out the responsibilities for the agencies involved in the process, and gives some indication of ways in which affected parties can play a part in the process.

Account freezing and forfeiture powers widely used by law enforcement agencies

North Yorkshire Police announced in October 2020 the recovery of over £300,000 by means of Account Freezing and Forfeiture Orders (AFrOs and AFoOs). The news serves as a reminder of the popularity and increasingly widespread use of this law enforcement power that was created under the Criminal Finances Act 2017.

Cannabis and the UK investor – two years on

Headlines such as “Spain becomes cannabis hub as criminals fill tourism void” (The Guardian 9 October 2020) serve to remind us of the endemic demand for marijuana, the resultant profits to be made and enforcement agencies’ inability to control Europe’s illegal trade run by drug mafias. By contrast, Canada, on 17 October 2018 and following the example of Uruguay, elected to legalise adult personal possession, sharing and cultivation of recreational cannabis.

The NCA finally obtains the benefit of Unexplained Wealth Orders

The NCA will be pleased as punch with the highly publicised outcome of their investigation into the businessman Mansoor Hussain; using several of the tools at its disposal, the agency has agreed a settlement with Mr Hussain that will see him relinquish ownership of numerous properties, assets and cash to the amount of £9,802,828. All on the basis of his alleged links to serious organised crime in the UK but without the need for any criminal proceedings.

Tackling Illicit Finance: SFO uses Listed Asset Order for first time

The SFO has followed in the footsteps of the NCA and HMRC by using, for the first time, a listed asset order (‘LAO’) to recover £500,000 worth of jewellery which they were satisfied represented the proceeds of crime.

The first NHS prescription for a child’s cannabis medicine - is the case of Billy Caldwell an outlier or the start of a trend?

For the first time, the NHS has agreed to fund a prescription for an unlicensed cannabis-based medicine product (CBMP) for a child. On 14 September 2020, the NHS announced its decision to fund the treatment of Billy Caldwell who is severely epileptic. This decision comes nearly two years after the law changed on 1 November 2018, allowing for CBMP’s to be prescribed by specialists for patients who cannot be helped by other available licensed drugs.

Will the Economic Crime Levy bring much needed investment in the fight against economic crime?

The Government announced its intention to introduce an Economic Crime Levy in the Budget 2020. This is designed to fund government action to tackle money laundering and help deliver the reforms committed to in the Economic Crime plan 2019-2020. It has since followed up on this - on 21 July - with the launch of a consultation as to how such a levy would operate.

NCA’s Annual Report 2019-20: a focus on recovering the proceeds of crime and asset denial

In the Home Secretary’s foreword to the National Crime Agency’s Annual Report 2019-20, she details the “NCA’s relentless mission to end the very worst criminality” and the report cites the categories of Serious and Organised Crime (SOC) that “destroy lives” including: child sexual abuse; modern slavery and human trafficking; organised immigration crime; cybercrime; fraud; money laundering; bribery and corruption; and, sanctions evasion.

City of London Police seize more than £2 million in cross-border money laundering operation

Media reports from 24 July 2020 inform us that the City of London Police (COLP) has seized more than £2 million held in British bank accounts as a result “of profits made by an Italian mafia gang”. We are told that Westminster Magistrates’ Court ordered the forfeiture of the cash after detectives submitted evidence that it was being channelled through London in a money-laundering operation.  

Further clarification on the rights of third parties in confiscation proceedings

The rights of third parties in confiscation proceedings have been the subject of scrutiny over recent years by the courts and legislature, as detailed in our blog, ‘The rights of third parties in confiscation matters: an inhospitable landscape’. The issue was considered most recently in the case of R v Hilton [2020] UKSC 29 in which the Supreme Court restated the law regarding when third parties may make representations to the court.

End of the road for the NCA in NCA v Baker

In our previous blog, ‘Unexplained Wealth Orders: An overview of the regime to date’ we considered the challenges faced by the NCA in their efforts to use the relatively new statutory tool of Unexplained Wealth Orders (UWOs). Unfortunately for the NCA, one of the four cases they have focused their efforts on since its introduction has now been unequivocally lost.

Share insightLinkedIn Twitter Facebook Email to a friend Print

Email this page to a friend

We welcome views and opinions about the issues raised in this blog. Should you require specific advice in relation to personal circumstances, please use the form on the contact page.

Leave a comment

You may also be interested in:

Skip to content Home About Us Insights Services Contact Accessibility